2621 - 2630 of 8571 Results
Title
Year
- Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings2019RESTRICTEDTitle: Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting ProceedingsJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0476-1Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-019-0476-1Citation Count: 9
-
RESTRICTEDTitle: Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and ShadowsJournal Name: CellsPublisher: MDPI AGVol: 8Issue #: 11Start Page: 1317End Page: 1317Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells8111317Best OA location URL: https://www.mdpi.com/2073-4409/8/11/1317/pdf?version=1571996609Citation Count: 23
-
RESTRICTEDTitle: Protein misfolding in neurodegenerative diseases: implications and strategiesJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-017-0077-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-017-0077-5Citation Count: 428
- Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry2023RESTRICTEDTitle: Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass SpectrometryJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 22Issue #: 8Start Page: 100608End Page: 100608Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mcpro.2023.100608Best OA location URL: http://www.mcponline.org/article/S1535947623001196/pdfCitation Count: 8
-
RESTRICTEDTitle: PAKs in the brain: Function and dysfunctionJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1864Issue #: 2Start Page: 444End Page: 453Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbadis.2017.11.005Best OA location URL: https://doi.org/10.1016/j.bbadis.2017.11.005Citation Count: 40
-
RESTRICTEDTitle: Review: Somatic mutations in neurodegenerationJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 44Issue #: 3Start Page: 267End Page: 285Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12465Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.12465Citation Count: 73
- Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid2023RESTRICTEDTitle: Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluidJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 4Start Page: 1179End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41596-022-00787-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561622Citation Count: 35
- Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options2018RESTRICTEDTitle: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current optionsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 352Issue #:Start Page: 142End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014Citation Count: 20
-
RESTRICTEDTitle: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseasesJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1237End Page: 1245Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990Best OA location URL: https://europepmc.org/articles/pmc5315368?pdf=renderCitation Count: 42
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action2016RESTRICTEDTitle: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 802End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013Citation Count: 246